The ReSPect Study - Reducing stigma towards people with issues related to drug use

2020年，英国有创纪录的4,517例与毒品有关的死亡。吸毒者（PWUD）面临着极端程度的污名化-导致差别待遇的负面陈规定型观念-限制了获得保健和药物治疗的机会，而保健和药物治疗是防止与毒品有关/全因死亡的保护措施。污名与支持减少伤害（HR）干预措施呈负相关，可能限制其提供。提供反污名信息的证据基础有限，而与此同时，污名被用作阻止吸毒的健康促进工具。制定信息干预措施，以减少对药物依赖者的污名化，并增加对减少药物相关危害的干预措施的支持。系统地审查有关信息传递的文献，以减少对残疾人的污名化。探讨医疗保健、药物治疗、公共卫生和政策利益相关者对PWUD的态度，以及他们对污名化的看法。确定不同类型的信息对专业/公众对PWUD、减少伤害和包容性医疗保健的态度的影响。在与公共卫生伦理学家、决策者和PWUD的研讨会上，探讨利用污名化的道德层面。为专业人员和公众制定和传播反对污名化的信息干预措施。

BackgroundThere were a record 4,517 drug-related deaths in the UK in 2020. People who use drugs (PWUD) face extreme levels of stigma - negative stereotyping leading to differential treatment - limiting access to healthcare and drug treatment, which are protective against drug-related/all-cause mortality. Stigma is negatively associated with support for harm reduction (HR) interventions, potentially limiting their provision. The evidence base informing anti-stigma messaging is limited, whilst simultaneously, stigma is exercised as a health promotion tool to deter drug use. AimDevelop messaging interventions to reduce stigma towards people with drug dependence and increase support for interventions to reduce drug-related harm.Objectives1. Systematically review literature on messaging to reduce stigma towards PWUD.2. Explore the attitudes of healthcare, drug treatment, public health, and policy stakeholders towards PWUD and their views on the instrumentalisation of stigma.3. Identify the impact of different types of messaging on professional/public attitudes towards PWUD, harm reduction and inclusion healthcare.4. Interrogate the ethical dimensions of instrumentalising stigma in workshops with public health ethicists, decisionmakers and PWUD.5. Develop and disseminate anti-stigma messaging interventions for professional and public audiences.